AAAAAA

   
Results: 1-25 |
Results: 25
GROWTH-HORMONE SECRETION IN HIV-POSITIVE VERSUS HIV-NEGATIVE HEMOPHILIC MALES WITH ABNORMAL GROWTH AND PUBERTAL DEVELOPMENT
Authors: KAUFMAN FR GERTNER JM SLEEPER LA DONFIELD SM GOMPERTS E KAUFMAN F NELSON M PEARSON S HILGARTNER M GERTNER J GOLDBERG I HOOTS WK LOVELAND K CANTINI M WILLOUGHBY A DONFIELD S MAEDER MA CONTANT C KISKER CT STEHBENS J BALE J COOL V SIROIS P SEXAUER C HUSZTI H HAWK S ARKIN S FORSTER A SWINDELLS S RICHARD S PARMLEY R MANGOS J SCOTT A HONECK L LUSHER J WARRIER I BAIRDCOX K HERSHEY MS EYSTER ME PATTISHALL E NEAGLEY S SHAPIRO A HATCHER S DAVIGNON G RABWIN P WICKLUND B SPOOR M
Citation: Fr. Kaufman et al., GROWTH-HORMONE SECRETION IN HIV-POSITIVE VERSUS HIV-NEGATIVE HEMOPHILIC MALES WITH ABNORMAL GROWTH AND PUBERTAL DEVELOPMENT, Journal of acquired immune deficiency syndromes and human retrovirology, 15(2), 1997, pp. 137-144
RECOMBINANT FVII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY AND INHIBITOR DEVELOPMENT AFTER 7 STUDY YEARS
Authors: LUSHER J ARKIN S ABILDGAARD CF HURST A
Citation: J. Lusher et al., RECOMBINANT FVII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY AND INHIBITOR DEVELOPMENT AFTER 7 STUDY YEARS, Thrombosis and haemostasis, 1997, pp. 664-664
INDEPENDENT EXPRESSION OF CD102 (ICAM-2) AND CD50 (ICAM-3), ON CD34 POSITIVE(+) HEMATOPOIETIC PROGENITORS
Authors: MENDELSON J ARKIN S LIPTON JM
Citation: J. Mendelson et al., INDEPENDENT EXPRESSION OF CD102 (ICAM-2) AND CD50 (ICAM-3), ON CD34 POSITIVE(+) HEMATOPOIETIC PROGENITORS, Experimental hematology, 24(9), 1996, pp. 291-291
KOGENATE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 7 STUDY YEARS
Authors: LUSHER J ARKIN S ABILDGAARD CF HURST D
Citation: J. Lusher et al., KOGENATE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 7 STUDY YEARS, Blood, 88(10), 1996, pp. 1755-1755
EVIDENCE FOR A SHIFT FROM A TYPE-I LYMPHOCYTE PATTERN WITH HIV DISEASE PROGRESSION
Authors: JASON J SLEEPER LA DONFIELD SM MURPHY J WARRIER I ARKIN S EVATT B WILLOUGHBY A WASSERMAN J PEQUEGNAT W GOMPERTS E KAUFMAN F NELSON M SCHULTZE ME PEARSON S HILGARTNER M GERTNER J SCIACCA J HOOTS WK LOVELAND K CANTINI M CURRY C MCKINLAY S DONFIELD S MAEDER MA CONTANT C KISKER CT STEHBENS J BALE J COOL V ANDES WA SIROIS P SEXAUER C OLSON R BOWMAN M HAWK S ALEDORT L ARROYO M HAIRE W ERICKSON J PARMLEY R MANGOS J SCOTT A HONECK L LUSHER J BAIRDCOX K HERSHEY MS EYSTER E PATTISHALL E SCHAFER J NEAGLEY CS SHAPIRO A HATCHER S DAVIGNON G MOLLEN P WICKLUND B SPOOR M
Citation: J. Jason et al., EVIDENCE FOR A SHIFT FROM A TYPE-I LYMPHOCYTE PATTERN WITH HIV DISEASE PROGRESSION, Journal of acquired immune deficiency syndromes and human retrovirology, 10(4), 1995, pp. 471-476
RECOMBINANT-FVIII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 5 STUDY YEARS
Authors: LUSHER J ARKIN S ABILDGAARD CF HURST D
Citation: J. Lusher et al., RECOMBINANT-FVIII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 5 STUDY YEARS, Thrombosis and haemostasis, 73(6), 1995, pp. 1012-1012
MODULATION OF ADHESION MOLECULE CD54 EXPRESSION ON CD34(+) HEMATOPOIETIC PROGENITORS
Authors: ARKIN S FERRONE S LIPTON JM
Citation: S. Arkin et al., MODULATION OF ADHESION MOLECULE CD54 EXPRESSION ON CD34(+) HEMATOPOIETIC PROGENITORS, Experimental hematology, 23(7), 1995, pp. 588-596
CONCORDANCE OF HUMAN-LEUKOCYTE ANTIGEN HAPLOTYPE-SHARING, CD4 DECLINEAND AIDS IN HEMOPHILIC SIBLINGS
Authors: KRONER BL GOEDERT JJ BLATTNER WA WILSON SE CARRINGTON MN MANN DL OBRIEN SJ WILLOUGHBY A KESSEL W DONFIELD SM MCKINLAY SM ALEDORT LM ARKIN S EYSTER ME PATTISHALL EG HILGARTNER MW KONKLE B WHITE GC COHEN AR BRAY GL LUBAN N KESSLER CM RAGNI MV LEDERMAN MM LEISSINGER C SIROIS P MANCOJOHNSON M DEMOERLOOSE P MAHE A HATZAKIS A MANDALAKI T SCHRAMM W EICHINGER S STINGL G GOMPERTS ED HOOTS WK LOVELAND KA KISKER CT STEHBENS AA CONTANT CF HUSZTI H SWINDELLS S MANGOS J WARRIER I SHAPIRO AD DAVIGNON GF WICKLUND BM WINKLER C
Citation: Bl. Kroner et al., CONCORDANCE OF HUMAN-LEUKOCYTE ANTIGEN HAPLOTYPE-SHARING, CD4 DECLINEAND AIDS IN HEMOPHILIC SIBLINGS, AIDS, 9(3), 1995, pp. 275-280
RECOMBINANT FVIII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY AND INHIBITORDEVELOPMENT AFTER 5 STUDY YEARS
Authors: LUSHER JM ARKIN S ABILDGAARD CF HURST D
Citation: Jm. Lusher et al., RECOMBINANT FVIII (KOGENATE) TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY AND INHIBITORDEVELOPMENT AFTER 5 STUDY YEARS, Pediatric research, 37(4), 1995, pp. 161-161
CD102 (ICAM-2) AND CD50 (ICAM-3), UNLIKE CD54 (ICAM-1) ARE CONSTITUTIVELY EXPRESSED ON HEMATOPOIETIC PROGENITORS
Authors: MENDELSON J ARKIN S LIPTON JM
Citation: J. Mendelson et al., CD102 (ICAM-2) AND CD50 (ICAM-3), UNLIKE CD54 (ICAM-1) ARE CONSTITUTIVELY EXPRESSED ON HEMATOPOIETIC PROGENITORS, Blood, 86(10), 1995, pp. 2685-2685
P53 STATUS IN AIDS LYMPHOMA CELL-LINES CORRELATES WITH SENSITIVITY TOCHEMOTHERAPY AND RADIATION-INDUCED APOPTOSIS
Authors: PIZZOLATO J GREENBERG D STREETER G MANFREDI J LACKNER C ARKIN S TENDLER C
Citation: J. Pizzolato et al., P53 STATUS IN AIDS LYMPHOMA CELL-LINES CORRELATES WITH SENSITIVITY TOCHEMOTHERAPY AND RADIATION-INDUCED APOPTOSIS, Blood, 86(10), 1995, pp. 2943-2943
PATTERN OF BLEEDING EPISODES IN YOUNG HEMOPHILIA-A PATIENTS - A NATURAL-HISTORY OF RECOMBINANT FACTOR-VIII (RFVIII) TREATMENT OF PREVIOUSLYUNTREATED PATIENTS (PUPS)
Authors: ARKIN S LUSHER J ABILDGAARD C BOGDANOFF D HURST D
Citation: S. Arkin et al., PATTERN OF BLEEDING EPISODES IN YOUNG HEMOPHILIA-A PATIENTS - A NATURAL-HISTORY OF RECOMBINANT FACTOR-VIII (RFVIII) TREATMENT OF PREVIOUSLYUNTREATED PATIENTS (PUPS), Blood, 86(10), 1995, pp. 3444-3444
DIFFERENTIAL-EFFECTS OF HIV-INFECTION ON T-HELPER(1) AND T-HELPER(2) LYMPHOCYTES OF HEMOPHILIC CHILDREN AND ADOLESCENTS
Authors: JASON J MURPHY J SLEEPER LA DONFIELD SM WARRIER I ARKIN S EVATT B GOMPERTS ED
Citation: J. Jason et al., DIFFERENTIAL-EFFECTS OF HIV-INFECTION ON T-HELPER(1) AND T-HELPER(2) LYMPHOCYTES OF HEMOPHILIC CHILDREN AND ADOLESCENTS, The FASEB journal, 8(4), 1994, pp. 10000494-10000494
IMMUNE AND SEROLOGIC PROFILES OF HIV-INFECTED AND NONINFECTED HEMOPHILIC CHILDREN AND ADOLESCENTS
Authors: JASON J MURPHY J SLEEPER LA DONFIELD SM WARRIER I ARKIN S EVATT B GOMPERTS ED
Citation: J. Jason et al., IMMUNE AND SEROLOGIC PROFILES OF HIV-INFECTED AND NONINFECTED HEMOPHILIC CHILDREN AND ADOLESCENTS, American journal of hematology, 46(1), 1994, pp. 29-35
ADLERIAN GROUP-THERAPY WITH SUBSTANCE-ABUSERS
Authors: PRINZ J ARKIN S
Citation: J. Prinz et S. Arkin, ADLERIAN GROUP-THERAPY WITH SUBSTANCE-ABUSERS, Individual psychology, 50(3), 1994, pp. 349-358
CD4 COUNTS IN HIV-NEGATIVE PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A RECEIVING RFVIII (KOGENATE)
Authors: WARRIER I LUSHER J ARKIN S ABILDGAARD C TENGBORN L HUTHKUEHNE A HURST D
Citation: I. Warrier et al., CD4 COUNTS IN HIV-NEGATIVE PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A RECEIVING RFVIII (KOGENATE), Transfusion, 34(8), 1994, pp. 732-733
CELL-CYCLE ANALYSIS IN FANCONI-ANEMIA - A DIAGNOSTIC-TEST
Authors: ARKIN S BRODTMAN D NAPRSTEK B NEUMAN R ALTER BP LIPTON JM
Citation: S. Arkin et al., CELL-CYCLE ANALYSIS IN FANCONI-ANEMIA - A DIAGNOSTIC-TEST, Pediatric research, 35(4), 1994, pp. 10000157-10000157
INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA RECEIVING KOGENATE - 4.5 YEAR FOLLOW-UP DATA, INCLUDING RESPONSE TO IMMUNE TOLERANCE (IT) WITH KOGENATE
Authors: LUSHER J ARKIN S ABILDGAARD C INWOOD M HILGARTNER M HURST D
Citation: J. Lusher et al., INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA RECEIVING KOGENATE - 4.5 YEAR FOLLOW-UP DATA, INCLUDING RESPONSE TO IMMUNE TOLERANCE (IT) WITH KOGENATE, Pediatric research, 35(4), 1994, pp. 10000165-10000165
KOGENATE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 5 STUDY YEARS
Authors: LUSHER J ARKIN S ABILDGAARD CF HURST D
Citation: J. Lusher et al., KOGENATE TREATMENT OF PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HEMOPHILIA-A - UPDATE OF SAFETY, EFFICACY, AND INHIBITOR DEVELOPMENT AFTER 5 STUDY YEARS, Blood, 84(10), 1994, pp. 10000239-10000239
A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE) - SAFETY, EFFICACY, AND INHIBITOR RISK IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A
Authors: BRAY GL GOMPERTS ED COURTER S GRUPPO R GORDON EM MANCOJOHNSON M SHAPIRO A SCHEIBEL E WHITE G LEE M GORDON M BERTALONE S LIPTON R HILGARTNER M ARKIN S GILL J KIM H SHURIN S SANTIAGOBORRERO P ARKEL YS KULKARNI R GREENWOOD MF RITCHEY AK WERNER E HAIRE WD KISKER T NEUFELD E EWENSTEIN B DEBIASI R LAURIAN Y KREUZ W RODEGHIERO F INGERSLEV J GAZENGEL C DIMICHELE D COOPER H
Citation: Gl. Bray et al., A MULTICENTER STUDY OF RECOMBINANT FACTOR-VIII (RECOMBINATE) - SAFETY, EFFICACY, AND INHIBITOR RISK IN PREVIOUSLY UNTREATED PATIENTS WITH HEMOPHILIA-A, Blood, 83(9), 1994, pp. 2428-2435
IMMUNE STATUS OF HUMAN-IMMUNODEFICIENCY-VIRUS SEROPOSITIVE AND SERONEGATIVE HEMOPHILIACS INFUSED FOR 3.5 YEARS WITH RECOMBINANT FACTOR-VIII
Authors: MANNUCCI PM BRETTLER DB ALEDORT LM LUSHER JM ABILDGAARD CF SCHWARTZ RS HURST D JOLLY K HARRISON J ADDIEGO JE JEREB R ARKIN S ALEDORT LM FOSTER A SEREMETIS S DASANI H HARRISON J HILGARTNER MW BOARDS N INWOOD MJ CLEGG E KASPER C MOCKARY P KRILL C DERY A MILLER E LEVINE P FORSBERG A VALDEZ L JACQUES S PFAFFMAN L WARRIOR I BRACKMANN HH GRINGERI A SANTAGOSTINO E SCHARRER I LEE C ALLRED RU BOGDANOFF D DONALDSON D MACKENZIE MA BAILEY P DYLA S PENNINGTON JE ZACCARINI P LEIGH P NEUMANN R FUKUI H
Citation: Pm. Mannucci et al., IMMUNE STATUS OF HUMAN-IMMUNODEFICIENCY-VIRUS SEROPOSITIVE AND SERONEGATIVE HEMOPHILIACS INFUSED FOR 3.5 YEARS WITH RECOMBINANT FACTOR-VIII, Blood, 83(7), 1994, pp. 1958-1962
MR-IMAGING OF DEFEROXAMINE-INDUCED BONE DYSPLASIA IN AN 8-YEAR-OLD FEMALE WITH THALASSEMIA MAJOR
Authors: MILLER TT CALDWELL G KAYE JJ ARKIN S BURKE S BRILL PW
Citation: Tt. Miller et al., MR-IMAGING OF DEFEROXAMINE-INDUCED BONE DYSPLASIA IN AN 8-YEAR-OLD FEMALE WITH THALASSEMIA MAJOR, Pediatric radiology, 23(7), 1993, pp. 523-524
INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATMENT PATIENTS (PUPS) WITH HEMOPHILIA RECEIVING KOGENATE - 4.5 YEAR FOLLOW-UP DATA, INCLUDING RESPONSE TO IMMUNE TOLERANCE (IT) WITH KOGENATE
Authors: LUSHER JM ARKIN S ABILDGAARD CF INWOOD M ZIMMERMANN R HILGARTNER M HURST D
Citation: Jm. Lusher et al., INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATMENT PATIENTS (PUPS) WITH HEMOPHILIA RECEIVING KOGENATE - 4.5 YEAR FOLLOW-UP DATA, INCLUDING RESPONSE TO IMMUNE TOLERANCE (IT) WITH KOGENATE, Blood, 82(10), 1993, pp. 10000153-10000153
A SCREENING-TEST FOR FANCONI-ANEMIA USING FLOW-CYTOMETRY
Authors: ARKIN S BRODTMAN D ALTER BP LIPTON JM
Citation: S. Arkin et al., A SCREENING-TEST FOR FANCONI-ANEMIA USING FLOW-CYTOMETRY, Blood, 82(10), 1993, pp. 10000176-10000176
CD-4 COUNTS IN HIV-NEGATIVE PREVIOUSLY UNTREATED PATIENTS (PUPS) WITHHEMOPHILIA-A RECEIVING RECOMBINANT FVIII (KOGENATE)
Authors: WARRIER I ARKIN S ABILDGAARD C TENGBOM L ZIMMERMANN R HURST D
Citation: I. Warrier et al., CD-4 COUNTS IN HIV-NEGATIVE PREVIOUSLY UNTREATED PATIENTS (PUPS) WITHHEMOPHILIA-A RECEIVING RECOMBINANT FVIII (KOGENATE), Blood, 82(10), 1993, pp. 10000601-10000601
Risultati: 1-25 |